Figure 2From: A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shockTNF-α serum concentrations following (A) single 250 U/kg dose of AZD9773; (B) multiple AZD9773 doses.Back to article page